Covered recipient · General Payments record
DONGKWAN JIN
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$4,576.79
- Reported across 166 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $754.99 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $176.33 | 8 |
| MDD US Operations, LLC | $134.76 | 6 |
| ABBVIE INC. | $68.27 | 3 |
| Lilly USA, LLC | $59.16 | 3 |
| CSL Behring | $51.48 | 2 |
| ARGENX US, INC. | $48.64 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $36.61 | 2 |
| Lundbeck LLC | $35.78 | 2 |
| PFIZER INC. | $34.35 | 2 |
| Neurocrine BioSciences, Inc. | $27.18 | 1 |
| SK Life Science, Inc. | $26.76 | 1 |
| Abbott Laboratories | $20.64 | 1 |
| Biogen, Inc. | $18.73 | 1 |
| Otsuka America Pharmaceutical, Inc. | $16.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.64 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125100380 | CMS |
| ABBVIE INC. | $16.09 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103997793 | CMS |
| ABBVIE INC. | $27.25 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103997795 | CMS |
| ABBVIE INC. | $24.93 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103997797 | CMS |
| ARGENX US, INC. | $20.86 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142102136 | CMS |
| ARGENX US, INC. | $27.78 | 06/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142106418 | CMS |
| Biogen, Inc. | $18.73 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104859648 | CMS |
| CSL Behring | $16.72 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134661791 | CMS |
| CSL Behring | $34.76 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134661841 | CMS |
| Lilly USA, LLC | $23.29 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136147433 | CMS |
| Lilly USA, LLC | $13.70 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136160717 | CMS |
| Lilly USA, LLC | $22.17 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136159079 | CMS |
| Lundbeck LLC | $15.93 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145929250 | CMS |
| Lundbeck LLC | $19.85 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145929252 | CMS |
| MDD US Operations, LLC | $24.60 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147767359 | CMS |
| MDD US Operations, LLC | $21.88 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147767355 | CMS |
| MDD US Operations, LLC | $23.26 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147756938 | CMS |
| MDD US Operations, LLC | $22.38 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147756936 | CMS |
| MDD US Operations, LLC | $19.02 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147756934 | CMS |
| MDD US Operations, LLC | $23.62 | 08/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147767357 | CMS |
| Neurocrine Biosciences, Inc. | $27.18 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150833244 | CMS |
| Novartis Pharmaceuticals Corporation | $21.99 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087037974 | CMS |
| Novartis Pharmaceuticals Corporation | $14.62 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087037976 | CMS |
| Otsuka America Pharmaceutical, Inc. | $16.30 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118915993 | CMS |
| PFIZER INC. | $16.14 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131167744 | CMS |
| PFIZER INC. | $18.21 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131402119 | CMS |
| SK Life Science, Inc. | $26.76 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154143824 | CMS |
| UCB, Inc. | $9.12 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143075508 | CMS |
| UCB, Inc. | $14.51 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143372972 | CMS |
| UCB, Inc. | $37.93 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143372976 | CMS |
| UCB, Inc. | $27.78 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143372981 | CMS |
| UCB, Inc. | $17.63 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143372985 | CMS |
| UCB, Inc. | $15.83 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143372989 | CMS |
| UCB, Inc. | $15.86 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143372994 | CMS |
| UCB, Inc. | $37.67 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143372998 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.